GLSI — Greenwich Lifesciences Balance Sheet
0.000.00%
Last trade - 00:00- $326.59m
- $316.08m
Annual balance sheet for Greenwich Lifesciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 27.2 | 13.5 | 6.99 | 4.09 | 6.18 |
| Total Current Assets | 27.2 | 13.5 | 6.99 | 4.09 | 6.18 |
| Net Intangible Assets | |||||
| Total Assets | 27.2 | 13.5 | 6.99 | 4.09 | 6.18 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.385 | 0.263 | 0.294 | 3.19 | 5.82 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.385 | 0.263 | 0.294 | 3.19 | 5.82 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 26.8 | 13.2 | 6.7 | 0.909 | 0.353 |
| Total Liabilities & Shareholders' Equity | 27.2 | 13.5 | 6.99 | 4.09 | 6.18 |
| Total Common Shares Outstanding |